136 related articles for article (PubMed ID: 9242457)
1. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.
Nehmé A; Baskaran R; Aebi S; Fink D; Nebel S; Cenni B; Wang JY; Howell SB; Christen RD
Cancer Res; 1997 Aug; 57(15):3253-7. PubMed ID: 9242457
[TBL] [Abstract][Full Text] [Related]
2. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells.
Nehmé A; Baskaran R; Nebel S; Fink D; Howell SB; Wang JY; Christen RD
Br J Cancer; 1999 Mar; 79(7-8):1104-10. PubMed ID: 10098743
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
Persons DL; Yazlovitskaya EM; Cui W; Pelling JC
Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
[TBL] [Abstract][Full Text] [Related]
4. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
5. Determination of cell fate by c-Abl activation in the response to DNA damage.
Kharbanda S; Yuan ZM; Weichselbaum R; Kufe D
Oncogene; 1998 Dec; 17(25):3309-18. PubMed ID: 9916993
[TBL] [Abstract][Full Text] [Related]
6. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation.
Cong F; Goff SP
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13819-24. PubMed ID: 10570156
[TBL] [Abstract][Full Text] [Related]
7. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.
Potapova O; Haghighi A; Bost F; Liu C; Birrer MJ; Gjerset R; Mercola D
J Biol Chem; 1997 May; 272(22):14041-4. PubMed ID: 9162025
[TBL] [Abstract][Full Text] [Related]
8. Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells.
Helbig L; Damrot J; Hülsenbeck J; Köberle B; Brozovic A; Osmak M; Fiket Z; Kaina B; Fritz G
J Biol Chem; 2011 Apr; 286(15):12991-3001. PubMed ID: 21324906
[TBL] [Abstract][Full Text] [Related]
9. Lack of c-Jun activity increases survival to cisplatin.
Sánchez-Pérez I; Perona R
FEBS Lett; 1999 Jun; 453(1-2):151-8. PubMed ID: 10403393
[TBL] [Abstract][Full Text] [Related]
10. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
Raitano AB; Halpern JR; Hambuch TM; Sawyers CL
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11746-50. PubMed ID: 8524841
[TBL] [Abstract][Full Text] [Related]
11. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents.
Kharbanda S; Ren R; Pandey P; Shafman TD; Feller SM; Weichselbaum RR; Kufe DW
Nature; 1995 Aug; 376(6543):785-8. PubMed ID: 7651539
[TBL] [Abstract][Full Text] [Related]
12. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage.
Kharbanda S; Pandey P; Yamauchi T; Kumar S; Kaneki M; Kumar V; Bharti A; Yuan ZM; Ghanem L; Rana A; Weichselbaum R; Johnson G; Kufe D
Mol Cell Biol; 2000 Jul; 20(14):4979-89. PubMed ID: 10866655
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage.
Gong JG; Costanzo A; Yang HQ; Melino G; Kaelin WG; Levrero M; Wang JY
Nature; 1999 Jun; 399(6738):806-9. PubMed ID: 10391249
[TBL] [Abstract][Full Text] [Related]
14. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms.
Pandey P; Raingeaud J; Kaneki M; Weichselbaum R; Davis RJ; Kufe D; Kharbanda S
J Biol Chem; 1996 Sep; 271(39):23775-9. PubMed ID: 8798604
[TBL] [Abstract][Full Text] [Related]
15. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Hayakawa J; Depatie C; Ohmichi M; Mercola D
J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
17. Impaired jun-NH2-terminal kinase activation by ultraviolet irradiation in fibroblasts of patients with Cockayne syndrome complementation group B.
Dhar V; Adler V; Lehmann A; Ronai Z
Cell Growth Differ; 1996 Jun; 7(6):841-6. PubMed ID: 8780897
[TBL] [Abstract][Full Text] [Related]
18. Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells.
Ohmori M; Shirasawa S; Furuse M; Okumura K; Sasazuki T
Cancer Res; 1997 Nov; 57(21):4714-7. PubMed ID: 9354428
[TBL] [Abstract][Full Text] [Related]
19. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines.
Vasilevskaya IA; Rakitina TV; O'Dwyer PJ
Mol Pharmacol; 2004 Jan; 65(1):235-43. PubMed ID: 14722256
[TBL] [Abstract][Full Text] [Related]
20. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
Kuroki DW; Bignami GS; Wattenberg EV
Cancer Res; 1996 Feb; 56(3):637-44. PubMed ID: 8564984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
